Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (701-710 of 774) with videos related to

Pageof 78
Sort By:
The American Journal of Cardiology|December 10, 2020
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New YorkEdward L Hannan, Yifeng Wu, Kimberly Cozzens, et al.
Digital Health|October 3, 2024
Sociodemographic predictors of successful screening and subsequent randomization in a digital health hypertension interventionHailey N Miller, Sandy Askew, Miriam B Berger, et al.
Circulation|May 16, 2002
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigationL A Szczech, P J Best, E Crowley, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
American Heart Journal|October 8, 2005
Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro studyCharles L Campbell, Peter B Berger, Greg A Nuttall, et al.
The New England Journal of Medicine|November 15, 2011
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarctionAdnan Kastrati, Franz-Josef Neumann, Stefanie Schulz, et al.
The American Journal of Cardiology|October 21, 2009
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry)Renato D Lopes, E Magnus Ohman, Christopher B Granger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturitionWilliam J Kaiser, Lisa P Daley-Bauer, Roshan J Thapa, et al.
Hypertension (Dallas, Tex. : 1979)|December 23, 2024
Effects of a Digital Intervention to Improve DASH and Blood Pressure Among US AdultsHailey N Miller, Sandy Askew, Miriam B Berger, et al.
Pageof 78

Showing results (701-710 of 774) with videos related to

Sort By:
Pageof 78
The American Journal of Cardiology|December 10, 2020
Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New YorkEdward L Hannan, Yifeng Wu, Kimberly Cozzens, et al.
Digital Health|October 3, 2024
Sociodemographic predictors of successful screening and subsequent randomization in a digital health hypertension interventionHailey N Miller, Sandy Askew, Miriam B Berger, et al.
Circulation|May 16, 2002
Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigationL A Szczech, P J Best, E Crowley, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
American Heart Journal|October 8, 2005
Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro studyCharles L Campbell, Peter B Berger, Greg A Nuttall, et al.
The New England Journal of Medicine|November 15, 2011
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarctionAdnan Kastrati, Franz-Josef Neumann, Stefanie Schulz, et al.
The American Journal of Cardiology|October 21, 2009
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry)Renato D Lopes, E Magnus Ohman, Christopher B Granger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturitionWilliam J Kaiser, Lisa P Daley-Bauer, Roshan J Thapa, et al.
Hypertension (Dallas, Tex. : 1979)|December 23, 2024
Effects of a Digital Intervention to Improve DASH and Blood Pressure Among US AdultsHailey N Miller, Sandy Askew, Miriam B Berger, et al.
Pageof 78